Affimed Financial Statements From 2010 to 2026
| AFMDDelisted Stock | USD 0.18 0.04 18.18% |
Check Affimed NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Affimed NV's main balance sheet or income statement drivers, such as , as well as many indicators such as . Affimed financial statements analysis is a perfect complement when working with Affimed NV Valuation or Volatility modules.
Affimed |
Affimed NV Company Shares Outstanding Analysis
Affimed NV's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Affimed NV Shares Outstanding | 16.39 M |
Most of Affimed NV's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Affimed NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Affimed NV has 16.39 M of shares currently outstending. This is 90.92% lower than that of the Biotechnology sector and 84.66% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 97.13% higher than that of the company.
Affimed NV Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Affimed NV's current stock value. Our valuation model uses many indicators to compare Affimed NV value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Affimed NV competition to find correlations between indicators driving Affimed NV's intrinsic value. More Info.Affimed NV is rated second in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Affimed NV by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Affimed NV Financial Statements
Affimed NV stakeholders use historical fundamental indicators, such as Affimed NV's revenue or net income, to determine how well the company is positioned to perform in the future. Although Affimed NV investors may analyze each financial statement separately, they are all interrelated. For example, changes in Affimed NV's assets and liabilities are reflected in the revenues and expenses on Affimed NV's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Affimed NV. Please read more on our technical analysis and fundamental analysis pages.
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany. Affimed NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 197 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Affimed Stock
If you are still planning to invest in Affimed NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Affimed NV's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |